| Probenecid
/
Colchicine |
| Trade Name(s): |
Probenecid and Colchicine ·Tablets
500 mg probenecid and 0.5 mg colchicine
Indicates Canadian Trade Name.
|
|
| Class: |
Agents for gout
|
Action: |
|
|
Probenecid
Inhibits tubular reabsorption of urate, thus increasing urinary excretion of uric acid.
|
|
Colchicine
Inhibits inflammation and reduces pain and swelling associated with gouty arthritis.
|
Indications: |
Treatment of chronic gouty arthritis when complicated by frequent, recurrent, acute attacks of gout.
|
Contraindications: |
Hypersensitivity to any component of product; children younger than 2 yr of age; known blood dyscrasias; uric acid kidney stones; current acute gouty attack.
|
Interactions: |
|
|
Acetaminophen, indomethacin, ketoprofen, lorazepam, meclofenamate, naproxen, rifampin
Plasma levels of these agents may be increased.
|
|
Beta-lactam antibiotics, penicillins
Psychic disturbances may occur.
|
|
Induction anesthesia (eg, thiopental)
Less anesthetic may be required.
|
|
Methotrexate
Probenecid increases plasma levels; methotrexate dose may need to be reduced.
|
|
Pyrazinamide, salicylates
Uricosuric action of probenecid may be antagonized.
|
|
Sulfonamides
Total sulfonamide (drug plus metabolite) levels may be increased.
|
|
Sulfonylureas
Risk of hypoglycemia may be increased.
|
Lab Test Interferences: |
Falsely high reading for theophylline may occur when measured by the Schack and Waxler technique.
|
Adverse Reactions: |
|
|
cns:
|
|
Probenecid
Headache; dizziness.
|
|
Colchicine
Peripheral neuritis.
|
|
dermatologic:
|
|
Probenecid
Urticaria; pruritus; dermatitis; alopecia; flushing.
|
|
Colchicine
Urticaria; purpura; alopecia; dermatitis.
|
|
gi:
|
|
Probenecid
Vomiting; nausea; anorexia; sore gums.
|
|
Colchicine
Nausea; vomiting; abdominal pain; diarrhea.
|
|
gu:
|
|
Probenecid
Nephrotic syndrome; uric acid stones with or without hematuria; renal colic; costovertebral pain; urinary frequency.
|
|
hematologic:
|
|
Probenecid
Aplastic anemia; leukopenia; hemolytic anemia.
|
|
Colchicine
Aplastic anemia; agranulocytosis.
|
|
hepatic:
|
|
Probenecid
Hepatic necrosis.
|
|
metabolic:
|
|
Probenecid
Precipitation of acute gouty arthritis.
|
|
miscellaneous:
|
|
Probenecid
Anaphylaxis; fever.
|
|
Colchicine
Muscular weakness.
|
Precautions: |
|
|
Pregnancy:
Category C
.
|
|
Lactation:
Undetermined.
|
|
Children:
Safety and efficacy not established; contraindicated in children younger than 2 yr of age.
|
|
Renal function impairment:
May not be effective in patients with chronic renal function impairment
(30 mL/min or less); dose may need to be increased.
|
|
Alkalinization of urine
May be needed to prevent hematuria, renal colic, costovertebral pain, formation of uric acid stones.
|
|
Exacerbation of gout
May occur.
|
|
Peptic ulcer
Use with caution in patients with history of peptic ulcer disease.
|
Overdosage: |
Signs & symptoms
Diarrhea, generalized vascular damage, renal damage, hematuria, oliguria.
|
Patient/Family Education: |
- Advise patient to take tablets as prescribed by health care provider.
- Advise patient to take without regard to meals but to take with food if GI upset occurs.
- Inform patient that dose will be slowly increased until max benefit is obtained.
- Advise patient to maintain adequate fluid intake (at least eight 8 oz glasses of water/day) and to carefully follow any instructions regarding alkalinizing the urine that were provided by health care provider.
- Caution patient to not increase the dose of this medication if gout symptoms should recur. Instruct patient to discuss other treatments for acute gout while continuing this medication.
- Caution patient to avoid concurrent use of aspirin or aspirin-containing products. Advise patient to use acetaminophen for management of mild to moderate pain.
- Advise patient to stop taking the drug and notify health care provider if persistent diarrhea or other GI symptoms occur, or if a rash or other signs of an allergic reaction develop.
|
 |
|